1-7 of 7
Levi A. Garraway
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genomic Evolutionary Patterns of Leiomyosarcoma and Liposarcoma

Ali Amin-Mansour, Suzanne George, Stefano Sioletic, Scott L. Carter, Mara Rosenberg, Amaro Taylor-Weiner, Chip Stewart, Aaron Chevalier, Sara Seepo, Adam Tracy, Gad Getz, Jason L. Hornick, Marisa R. Nucci, Bradley Quade, George D. Demetri, Chandrajit P. Raut, Levi A. Garraway, Eliezer M. Van Allen, Andrew J. Wagner
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (16): 5135–5142.
https://doi.org/10.1158/1078-0432.CCR-19-0271
Published: 15 August 2019
View articletitled, Genomic Evolutionary Patterns of Leiomyosarcoma and Liposarcoma
Open the PDF for Genomic Evolutionary Patterns of Leiomyosarcoma and Liposarcoma in another window
Includes: Supplementary data
Journal Articles

Genomic Heterogeneity and Exceptional Response to Dual Pathway Inhibition in Anaplastic Thyroid Cancer

William J. Gibson, Daniel T. Ruan, Vera A. Paulson, Justine A. Barletta, Glenn J. Hanna, Stefan Kraft, Antonio Calles, Matthew A. Nehs, Francis D. Moore, Jr, Amaro Taylor-Weiner, Jeremiah A. Wala, Travis I. Zack, Thomas C. Lee, Fiona M. Fennessy, Erik K. Alexander, Tom Thomas, Pasi A. Janne, Levi A. Garraway, Scott L. Carter, Rameen Beroukhim, Jochen H. Lorch, Eliezer M. Van Allen
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (9): 2367–2373.
https://doi.org/10.1158/1078-0432.CCR-16-2154-T
Published: 30 April 2017
View articletitled, Genomic Heterogeneity and Exceptional Response to Dual Pathway Inhibition in Anaplastic Thyroid Cancer
Open the PDF for Genomic Heterogeneity and Exceptional Response to Dual Pathway Inhibition in Anaplastic Thyroid Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract B39: Genomic copy number alterations introduce a gene-independent viability bias in CRISPR-Cas9 knock-out screens of cancer cell lines

Robin M. Meyers, Andrew J. Aguirre, Barbara A. Weir, Francisca Vazquez, Cheng-Zhong Zhang, Uri Ben-David, April Cook, Gavin Ha, William F. Harrington, Mihir Doshi, Stanley Gill, Han Xu, Levi D. Ali, Guozhi Jiang, Sasha Pantel, Yenarae Lee, Amy Goodale, Andrew D. Cherniack, Coyin Oh, Gregory Kryukov, Glenn S. Cowley, Levi A. Garraway, Kimberly Stegmaier, Charles W. Roberts, Todd R. Golub, Matthew Meyerson, David E. Root, Aviad Tsherniak, William C. Hahn
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (1_Supplement): B39.
https://doi.org/10.1158/1557-3265.PMCCAVULN16-B39
Published: 02 January 2017
View articletitled, Abstract B39: Genomic copy number alterations introduce a gene-independent viability bias in CRISPR-Cas9 knock-out screens of cancer cell lines
Journal Articles

Genetic Effect of Chemotherapy Exposure in Children of Testicular Cancer Survivors

Gregory V. Kryukov, Craig M. Bielski, Kaitlin Samocha, Menachem Fromer, Sara Seepo, Carleen Gentry, Benjamin Neale, Levi A. Garraway, Christopher J. Sweeney, Mary-Ellen Taplin, Eliezer M. Van Allen
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (9): 2183–2189.
https://doi.org/10.1158/1078-0432.CCR-15-2317
Published: 01 May 2016
View articletitled, Genetic Effect of Chemotherapy Exposure in Children of Testicular Cancer Survivors
Open the PDF for Genetic Effect of Chemotherapy Exposure in Children of Testicular Cancer Survivors in another window
Includes: Supplementary data
Journal Articles

Abstract B33: Integration of genome-wide datasets identifies SOX10 as a lineage-specific genetic dependency in melanoma

Terence C. Wong, Cory M. Johannessen, Levi A. Garraway
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (4_Supplement): B33.
https://doi.org/10.1158/1557-3265.PMS14-B33
Published: 13 February 2015
View articletitled, Abstract B33: Integration of genome-wide datasets identifies SOX10 as a lineage-specific genetic dependency in melanoma
Journal Articles

Abstract PR02: Identification of ERK1/2 mutations that confer resistance to MAPK pathway inhibitors

Eva M. Goetz, Mahmoud Ghandi, Daniel Treacy, Nikhil Wagle, Levi A. Garraway
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (4_Supplement): PR02.
https://doi.org/10.1158/1557-3265.PMS14-PR02
Published: 13 February 2015
View articletitled, Abstract PR02: Identification of ERK1/2 mutations that confer resistance to MAPK pathway inhibitors
Journal Articles

High-throughput oncogene mutation detection in human cancers by mass spectrometry-based genotyping

Roman K. Thomas, Alissa C. Baker, Ralph DeBiasi, Whei Feng, Thomas LaFramboise, Meng Wang, Jeffrey C. Lee, Richard Nicoletti, Charles Hatton, Liuda Ziagra, Stacey B. Gabriel, Caroline M. Emery, Heidi Greulich, Mark A. Rubin, Massimo Loda, Jonathan Fletcher, Fred J. Kaye, Kenneth C. Anderson, George D. Demetri, Reinhard Dummer, Stephan N. Wagner, Meenhard Herlyn, William R. Sellers, Matthew L. Meyerson, Levi A. Garraway
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19_Supplement): A106.
Published: 15 August 2014
View articletitled, High-throughput oncogene mutation detection in human cancers by mass spectrometry-based genotyping